Vascular Solutions (VASC) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Piper Jaffray Raises Price Target on Vascular Solutions (VASC) Following First Earnings Report Since DOJ Litigation
April 26, 2016 8:10 AM EDTPiper Jaffray reiterated an Overweight rating on Vascular Solutions (NASDAQ: VASC), and raised the price target to $45.00 (from $44.00), following the company's 1Q earnings report. VASC reported revenue of $39.4M vs. consensus of $38.5M and adjusted EPS of $0.26 vs. consensus of $0.23. This is the company's first quarterly earnings call since the not-guilty verdict of... More



